drugset / Trial / NCT06283979

A Randomized Controlled Phase II Trial of STIMULAN VG vs Standard of Care (SoC) for the Treatment of Osteomyelitis Associated With Stage IV Pressure Ulcers.

NCT06283979 ↗

Phase 2 Recruiting 60 enrolled Biocomposites Ltd MCRA · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this trial is to assess the safety, tolerability and between-group effect size of STIMULAN VG (with debridement) and a course of systemic antibiotics to standard of care (debridement and systemic antibiotics only) for the treatment of osteomyelitis associated stage IV pressure ulcers.

Timeline

Start
2025-06-15
Primary completion
2026-12-01
Completion
2026-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject STIMULAN VG Unknown — —